These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 22108472)

  • 1. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
    Ippolito E; Belcaro G; Dugall M; Cesarone MR; Feragalli B; Errichi BM; Gizzi G; Pellegrini L; Ledda A; Luzzi R; Ricci A; Bavera P; Hosoi M; Corsi M; Errichi S
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):13-9. PubMed ID: 22108472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study.
    Cesarone MR; Belcaro G; Ippolito E; Pellegrini L; Ledda A; Luzzi R; Ricci A; Dugall M; Bavera P; Hosoi M; Stuard S; Corsi M
    Panminerva Med; 2010 Jun; 52(2 Suppl 1):43-8. PubMed ID: 20657534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy.
    Cesarone MR; Belcaro G; Grossi MG; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cacchio M
    Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):55-61. PubMed ID: 19597413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
    Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
    Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial.
    Kiesewetter H; Koscielny J; Kalus U; Vix JM; Peil H; Petrini O; van Toor BS; de Mey C
    Arzneimittelforschung; 2000 Feb; 50(2):109-17. PubMed ID: 10719612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M
    Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
    Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LONFLIT4-Venoruton Study: a randomized trial--prophylaxis of flight-edema in venous patients.
    Cesarone MR; Belcaro G; Brandolini R; Di Renzo A; Bavera P; Dugall M; Simeone E; Acerbi G; Ippolito E; Winford M; Candiani C; Golden G; Ricci A; Stuard S
    Angiology; 2003; 54(2):137-42. PubMed ID: 12678187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a short course of complex lymphedema therapy or graduated compression stocking therapy in the treatment of post-thrombotic syndrome.
    Holmes CE; Bambace NM; Lewis P; Callas PW; Cushman M
    Vasc Med; 2014 Feb; 19(1):42-8. PubMed ID: 24558028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of elastic compression stockings used early or after resolution of the edema on recanalization after deep venous thrombosis: the COM.PRE Trial.
    Arpaia G; Cimminiello C; Mastrogiacomo O; de Gaudenzi E
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):131-7. PubMed ID: 17287629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial.
    Aschwanden M; Jeanneret C; Koller MT; Thalhammer C; Bucher HC; Jaeger KA
    J Vasc Surg; 2008 May; 47(5):1015-21. PubMed ID: 18372153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins.
    Cesarone MR; Belcaro G; Ricci A; Brandolini R; Pellegrini L; Dugall M; Di Renzo A; Vinciguerra G; Gizzi G; Cornelli U; Errichi BM; Corsi M; Ippolito E; Adovasio R; Cacchio M; Stuard S; Larnier C; Candiani C; Cerritelli F
    Angiology; 2005; 56(3):289-93. PubMed ID: 15889196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Ippolito E; Fano F; Dugall M; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    Phytomedicine; 2010 Sep; 17(11):835-9. PubMed ID: 20579863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
    Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence. Under the auspices of the IUP.
    Partsch H; Flour M; Smith PC;
    Int Angiol; 2008 Jun; 27(3):193-219. PubMed ID: 18506124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.